Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies

Inclusion Criteria: * Subjects must have histologically or cytologically confirmed metastases to the peritoneum from gastrointestinal cancer, ovarian cancer or mesothelioma prior to surgery. * Subjects must be scheduled for surgical resection. * Age of 18 years or older. * Subjects must be able and willing to follow study procedures and instructions. * Subjects must have received and signed an informed consent form. * Subjects must be otherwise healthy except for the diagnosis of cancer, as per the criteria listed below. * Subjects must have normal organ and marrow function as defined as: * Leukocytes \> 3,000/mcL * Absolute neutrophil count \> 1,500/mcL * Platelets \> 100,000/mcL * total bilirubin within normal institutional limits * AST (SGOT)/ALT (SGPT) \< 2.5 X institutional upper limit of normal * Creatinine within normal institutional limits or creatinine clearance \> 60 mL/min/1.73 m2 for subjects with creatinine levels above institutional normal. * Subjects with ECOG performance status of 0 or 1. Exclusion Criteria: * Subjects who are pregnant or nursing at the time of diagnosis. * Subjects who are sexually active and not willing/able to use medically acceptable forms of contraception (hormonal or barrier method of birth control, abstinence) upon entering the study and for 60 days after injection of LUM015. * Subjects who have taken an investigational drug within 30 days of enrollment. * Subjects who have not recovered from adverse events due to other …